Brilliantly specialized in conceptualizing, developing and producing innovative medical devices and services – d heart It is an Italian biomedical start-up founded in 2015 by Niccol Bryant and Niccol Morezzi.
Today, even with wearable devices Like Fitbit and Apple Watch – the main challenge in healthcare is getting concrete medical conclusions from the data collected.
“With a mission to advance the prevention of cardiovascular disease and shape the ultimate expression of personalized medicine – D-Heart is the first clinically reliable, easy-to-use, portable and affordable smart ECG device.” Bryant says.
Even with no medical background, it allows a person to perform a hospital-wide EKG in complete independence and send the results to a 24/7 cardiology service or a trusted doctor.
Beautifully reflecting the D-Heart brand, simplicity meets reliability – every element of physical device To the digital application and packaging design Italy design group.
Turning ideas into reality with a 360-degree approach – Design Group Italia is a multidisciplinary international design studio headquartered in Milan.
By mastering the intersection between the physical and the digital, they innovatively envision the future through data and research and create tangible solutions to bring about meaningful change.
With cardiovascular disease being the leading cause of death and at the center of the global health agenda – DesignWanted decided to interview Nicolò Briante (Co-Founder of D-Heart) and Edgardo Angelini (Partner of D-Heart). Italy design group).
Scroll to step into the future of medicine and learn more about this game-changing smart ECG device:
Can you tell us more about the founders of D-Heart – Nicolò Briante e Niccolò Maurizi and how you met?
Nicolo Bryant: I met Niccol Morezzi at university. At that time, we were two young students in a multidisciplinary environment at the Almo Colegio Borromeo in Pavia.
Morezzi was a young medical researcher in cardiology at the University of Florence. When he was 16, he had a myocardial infarction and decided to become a doctor and turn his problem into an opportunity.
Putting our will and our dream together, we created D-Heart – the first smartphone ECG device that skillfully combines patient-required usability with clinician-wanted ECG reliability.
How did the idea of D-Heart and the portable electrocardiogram come about?
Nicolo Bryant: The idea of D-Heart and a portable ECG device originated from a magazine – international – in which we subscribed.
This magazine summarizes reflections of great value collected by journalists. However, of all the articles – two of them caught our attention.
The first challenged the myth that cancer – the biggest preoccupation of the 21st century – was the leading cause of death.
Although the data is actually analyzed at the geographical and demographic level – their numbers are low compared to other types of deadly diseases.
Among all the cardiovascular diseases from stroke to heart attack are the most life-threatening diseases today.
Cardiovascular diseases affect both developed and less developed countries.
This led us to devise a method that makes prevention and monitoring of cardiovascular disease easier outside of hospitals.
The second article is about cell phones that today have a lot of processing power – much higher than computers in the year 2000 – but have not yet been exploited to the maximum capacity.
Among the endless number of potential uses, the article went on to highlight how a mobile phone can be used to perform diagnostic tests at home or in a pharmacy.
This is how the opportunity and the idea of D-Heart – a portable electrocardiogram – were born.
How was the first D-Heart prototype made?
Nicolo BryantD-Heart’s first 3D-printed prototype. However, this electrocardiogram can only make a limited diagnosis.
Then we moved on to explore more and found a company that had the skills to perfect the model.
How was the first funding raised to start this idea?
Nicolo Bryant: We started this inspiring journey without money at the age of 23.
With that in mind, we then moved on to getting funding by several companies and organizations with our best promotion being word of mouth.
With the Vodafone Foundation – we received its first funding of $30,000 which was used for prototype and product tests on healthcare professionals and patients.
This was followed by our second funding of $200,000 in which we added new features as there were small issues related to product usability that had to be addressed with priority.
After a lot of brainstorming about what changes to make and how to implement them – developed in collaboration with Design Group Italia as well as the engineering and production team that took care of the product and its smartphone integration.
Why was Design Group Italia chosen to design this product?
Nicolo Bryant: With no background in design whatsoever – we were looking for a studio to collaborate with, a company with a prestigious history that qualified for this type of project.
We came across Design Group Italia and after taking a look at their range of products we realized how it went perfectly with what we wanted.
Our goal was to facilitate service delivery and not just make a new product – a mix of eclectic elements that only a reality like Design Group Italia could develop seamlessly.
What is the role and importance of design in this project?
Nicolo Bryant: Today, medical devices don’t put people at ease, and we wanted D-Heart to be appreciated by everyone, as its design needs the most attention.
A solution was needed so that the chronic patient could feel comfortable and only good design was the solution.
With great attention to intricate detail, ease of use, practicality, and aesthetics – D-Heart has continued to blend clinical reliability harmoniously with ease of use, standing out in the medical market.
Like – thanks to image processing and artificial intelligence, one can easily guide one to the correct electrode position by showing their own chest photo with virtual markings where one should stick to the electrodes.
What difficulties did you encounter during this project?
Nicolo Bryant: D-Heart aims to lower costs compared to today’s public health services by providing in-home monitoring and prevention.
However, the difficulties encountered were the regulation of the market which is very expensive and limits innovation in Europe!
Taking a Social Stand Worldwide – D-Heart is used in cardiovascular screening campaigns today by NGOs and private foundations, as well as beneficiary companies in Senegal, Kenya, Uganda, Tanzania, Bangladesh and more.